Planning for Success Biotechnology Product Development

Slides:



Advertisements
Similar presentations
Mary Ellen Turner MD, MPH Vice-President
Advertisements

The Drug Discovery Process
Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.
JMV 1843 pharmacological profile
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Working with FDA: Biological Products and Clinical Development Critical Path.
FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.
Development and Review Process of NDA, ANDA/AADA and OTC Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Associate Professor Department of Pharmaceutics KLE.
Stefan Franzén Introduction to clinical trials.
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
Drug Discovery Process
Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Working with FDA: Biological Products and Clinical Development IND Case Studies.
Overview of the New Content and Format Requirements for Prescription Drug Labeling.
Stages of drug development
Basis for Neulasta® (Pegfilgrastim) Approval
The Drug Development Process
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Obtaining and Negotiatiing a Position in Industry/Biotech Roy G. Smith Ph.D. Director, Huffington Center on Aging Professor, Department of Molecular and.
Clinical Trials Amir Zarrinhaghighi
Stefan Franzén Introduction to clinical trials.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,
Exploratory IND Studies
Investigational Drugs Drug Laws, Drug Approval Process.
Nonclinical Perspective on Initiating Phase 1 Studies for Small Molecular Weight Compounds John K. Leighton, PH.D., DABT Supervisory Pharmacologist Division.
CHEE DRUG PRODUCT DEVELOPMENT u Drug ä agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in man or animals.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
Introduction to Pharmacology PHARM TECH. Pharmacology  Pharmacology is the science that deals with the study of therapeutic (beneficial) agents.  Knowledge.
Concepts and Applications of Pharmacokinetics
Risk Management in premarketing phase Anshu Vashishtha MD PhD (in individual capacity employer : Watson Pharmaceuticals)
DIVISION OF REPRODUCTIVE AND UROLOGIC PRODUCTS Physician Labeling Rule Lisa Soule, M.D.
1/33.  What is INDA ?  Types of INDAs  Objectives of INDAs  Format & Contents of an INDA  IND Safety reports  IND Annual Reports  IND Review Process.
The New Drug Development Process (www. fda. gov/cder/handbook/develop
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
History of Pediatric Labeling
COMPARABILITY PROTOCOLUPDATE ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE Manufacturing Subcommittee July 20-21, 2004 Stephen Moore, Ph.D. Chemistry Team.
Mad Hatter’s Tea Party 12th June 2013 “I can't go back to yesterday because I was a different person then.” ― Lewis Carroll, Alice in WonderlandLewis CarrollAlice.
FDA Office of Orphan Products Development
Labeling and Electronic Initiatives Rachel E. Behrman M.D., M.P.H. Deputy Director, Office of Medical Policy CDER FDA Science Board, April 15, 2005.
“Journey of a Drug” From Test Tube TO Prescribing Physician.
FDA Presentation to the Oncologic Drugs Advisory Committee Tositumomab Therapeutic Regimen Corixa Corporation BLA December 17, 2002.
Ameeta Parekh, Ph.D. CDER/OCPB CPSC Meeting November 17/18
Drug Regulation, Development, Names, and Information Chapter 3 Copyright (c) 2004 Elsevier Inc. All rights reserved.
Clinical Trials - PHASE II. Introduction  Important part of drug discovery process  Why important??  Therapeutic exploratory trial  First time in.
Phases of Therapeutic Development by Virinder Nohria, MD, PhD Presented at ASENT Annual Meeting Symposium on Neurotherapeutics Arlington, VA March 6, 2008.
1 IND Applications for Academic Clinical Investigations John Marler, MD US Food and Drug Administration New Hampshire Avenue White Oak, MD
httpwww.youtube.com/watch?v=DhxD6sVQEYc:// The Drug Discovery Process.
독성학 박 대 훈 한약재산업학과
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
The process of drug development. Drug development 0,8 – 1 mld. USD.
Clinical Trials.
FDA DRUG APPROVAL FDA’s Lengthy Drug Approval Process in Twelve Steps Overview of the FDA Drug Approval Process Drug Developed June 13, 2016 | Emilia Varrone.
Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: - relationship.
Drug Development Process Stages involved in Regulating Drugs
The Stages of a Clinical Trial
New Drug Application(NDA) Vs Abbreviated new drug application (ANDA)
Drug Discovery &Development
Regulatory– Terms & Definitions רגולציה - מונחים והגדרות
Schedule 2 Drugs Henderson.
Prof. Dr. Basavaraj K. Nanjwade
Globular Protein Made of amino acid chains
9.4 Product Quality Control
Labeling and Electronic Initiatives
Drug Development Stages
Drug and Drug Products Quality & Testing
Drug Design and Drug Discovery
By Amany Helmy Hasanin Assistant Professor of Clinical Pharmacology
Dosage Form Design Lecture 1 17/2/2019 Dr. Athmar Dhahir Habeeb
Considerations for Successful Biopharmaceutical Product Development: Discovery to Proof of Concept -A Panel Discussion Stanley C. McDermott, PharmD, MS,
Presentation transcript:

Planning for Success Biotechnology Product Development Michael J. Roy, PhD, RAC

On Developing a Product 'Begin at the beginning,‘ the King said, very gravely, ‘and go on till you come to the end: then stop.‘ Lewis Carroll. Alice’s Adventures in Wonderland

Biotechnology Product Development Research and Discovery Define Product and Development Objectives Targeted Product Profile (TPP or Draft Label) Introduce Development Scheme Product Development Plan (PDP or PDS) Develop Product Preclinical Phase 1, Phase 2, Phase 3 Market Approval

On Developing a Product ‘If you don't know where you are going, any road will get you there.’ Lewis Carroll. Alice’s Adventures in Wonderland

Product Development Planning Execute Small-Scale Manufacturing Characterization Pharmacology Toxicology IND Phase 1 Phase 2 Full-Scale Manufacturing Phases 3 & 4 NDA/BLA Project Plan Target Product Profile Planning Process 12

Discovery to Market Timeline Submit BLA BLA Approval Submit IND Preclinical Research Clinical Development BLA Review Synthesis and Physical Characterization Formulation Scale-up Pharmacology and Pharmacokinetics Animal Safety Testing Phase I Phase II Phase III Phase IV 12-24 months 6-9 months 6-18 months 1 month 9-12 months Adapted from www.fda.gov 12-24 months

Development Planning Process Assemble a Team Plan, Working Backwards Draft a Targeted Product Profile Consider Product Design Revise Targeted Product Profile Produce a Product Development Plan Begin Development, Working Forwards Product Development

Product Development Planning Execute Small-Scale Manufacturing Characterization Pharmacology Toxicology IND Phase 1 Phase 2 Full-Scale Manufacturing Phases 3 & 4 NDA/BLA Project Plan Target Product Profile Planning Process 12

Assemble a Team Development: Functional Areas Operational Area Definition Project Management Lead: Planning, organization and management of project Regulatory Affairs Regulatory climate, aspects, functions, global and national. Quality Assurance Support to ensure that all efforts are of highest quality Biomanufacture Produce or manufacture product Quality Control Ensure quality product through laboratory testing. Nonclinical Design and perform pharmacology and toxicology Clinical Evaluate safety and effectiveness of product in humans

On Product Development Teams 'But I don't want to go among mad people,' said Alice. 'Oh, you can't help that,' said the cat. 'We're all mad here.' Lewis Carroll. Alice’s Adventures in Wonderland

Targeted Product Profile Trade & Chemical Name Description Indications & Usage Dosage, Administration How Supplied Clinical Pharmacology Clinical Studies Warnings & Precautions Contraindications Adverse Reactions Over Dosage Patient Information References

TPP Example : A Therapeutic Monoclonal Antibody Trade & Chemical Name: Cladaxacumab (Cab) Description: Cab is a humanized monoclonal antibody that binds to XYZ surface protein , Chlamydia trachomatis Indications & Usage: Cab is used to treat acute eye infections in children between the ages of ….. Dosage, Administration: Cab is given as a 0.2 mL dose, four time daily by… How Supplied: Cab is supplied as a liquid, monoclonal antibody suspended in an ophthalmic formulation of…. Must be kept refrigerated….

TPP Example: A Therapeutic Monoclonal Antibody Clinical Pharmacology: Cab following treatment remains in the eye for up to two hours at a concentration range of…. Clinical Studies: Cab was shown to be safe and effective in two pivotal clinical studies, one in children with….. Warnings & Precautions: Cab has no known systemic toxicity but it can cause irritation to the eye due to…. Contraindications: Cab should not be used in children with the following underlying conditions…..

TPP Example: A Therapeutic Monoclonal Antibody Adverse Reactions: In two placebo-controlled randomized clinical studies, Cab had an….in Table 1…. Over Dosage: Dosage of Cab greater than 0.2 mL or more frequently than once every 2 hours may cause…. Patient Information: Parents or guardians of children taking Cab should keep the product refrigerated before use… References: Jones, CP and Taylor AA. 2010….

Consider Product Design Is the product designed to meet objectives? Critical review by experts If not, redesign to meet objectives Modify product in the laboratory Example monoclonal antibody Humanize Improve specificity

Product Development Plan Specific: one product, one indication All steps to meet objectives (in TPP) Tasks identified under functional headings Begins at the end and Ends at the beginning of product development

Product Development Planning Execute Small-Scale Manufacturing Characterization Pharmacology Toxicology IND Phase 1 Phase 2 Full-Scale Manufacturing Phases 3 & 4 NDA/BLA Project Plan Target Product Profile Planning Process 12

Phased Product Development Planning Phase 3 to Phase 2 to Phase 1 to Preclinical

Product Development Plan: Phase 3 and Market Clinical Phase 3 Plan Manufacturing Plan: Phase 3 & Market Quality control plan for Phase 3 product Regulatory plan for Phase 3 and Application Nonclinical plan for…. Quality Assurance plan for…

Product Development Plan: Phase 2 Clinical Phase 2 Plan: Manufacturing plan for Phase 2 Quality Control plan for Phase 2 product Regulatory plan for Phase 2 and Application Nonclinical plan for…. Quality Assurance plan for…

Product Development Plan: Phase 1 Clinical Phase 1 Plan Manufacturing Plan for Phase 1 Quality control plan for Phase 1 product Regulatory plan for Phase 1 and Application Nonclinical plan for…. Quality Assurance plan for…

Product Development Plan: Preclinical Redesign Product Modify Product Additional research Formulation efforts

Recycle the PDP Will the plan achieve objectives stated in TPP? Review plan forward, beginning from preclinical Compare against objectives in TPP If not, revise plan or the TPP until they match

Product Development Planning Execute Small-Scale Manufacturing Characterization Pharmacology Toxicology IND Phase 1 Phase 2 Full-Scale Manufacturing Phases 3 & 4 NDA/BLA Project Plan Target Product Profile Planning Process 12

In Summary Plan for success Prepare a TPP (Objectives) Write a PDP (Plan) Revise Targets & Plan TPP can be met PDP meets objectives

Looking Ahead by Planning Backwards